MRSA
|
Previous infection/colonization by MRSA in the last 12 months
Hemodialysis or peritoneal dialysis
Presence of central venous catheters or intravascular devices
Administration of multiple antibiotics in the last 30 days (in particular with cephalosporins or fluoroquinolones)
Immunodepression
Immunosuppressor treatments
Rheumatoid arthritis
Drug addiction
Patients coming from long-term care facilities or who have undergone hospital stay in the last 12 months
Close contact with patients colonized by MRSA
|
ESBL
|
Previous infection/colonization with ESBL in the last 12 months
Prolonged hospitalization (>10 days, in particular in ICU/hospice/long-term care facilities)
Presence of permanent urinary catheter
Administration of multiple antibiotics in the last 30 days (particularly with cephalosporins or fluoroquinolones)
Patients with percutaneous endoscopic gastrostomy
|
Pseudomonas aeruginosa
|
Previous infection/colonization with P. aeruginosa in the last 12 months
Administration of multiple antibiotics in the last 30 days (particularly with cephalosporins or fluoroquinolones)
Pulmonary anatomic abnormalities with recurrent infections (e.g., bronchiectasis)
Elderly patients (>80 years)
Scarce glycemic control in diabetic subjects
Presence of permanent urinary catheter
Prolonged steroid use (>6 weeks)
Neutropenic fever
Cystic fibrosis
|
Candida spp.
|
Immunodepression
Presence of central venous catheters or intravascular devices
Patients in total parenteral nutrition
Prolonged hospitalization (>10 days, particularly in an ICU)
Recent surgery (particularly abdominal surgery)
Prolonged wide-range antibiotic administration
Previous necrotizing pancreatitis
Recent fungal infection/colonization
|